World's Best Scientists 2026 revealed!
Manuel R. Teixeira

Manuel R. Teixeira

D-Index & Metrics

Medicine

D-Index
82
Citations
25062
World Ranking
16099
National Ranking
17

Manuel R. Teixeira publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Manuel R. Teixeira sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 444 publications — 48th percentile

48% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Manuel R. Teixeira D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Manuel R. Teixeira sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 82 D-Index — 21st percentile

21% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Manuel R. Teixeira is affiliated with the University of Porto in Portugal and has an extensive research portfolio primarily in Medicine and Biochemistry, Genetics and Molecular Biology. Their work spans several subfields including Genetics, Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, and Cancer Research.

The scientist's research focuses on topics such as:

  • Genetic factors in colorectal cancer
  • BRCA gene mutations in cancer
  • Cancer Genomics and Diagnostics
  • Prostate Cancer Treatment and Research
  • Genetic Associations and Epidemiology
  • DNA Repair Mechanisms
  • Molecular Biology Techniques and Applications

Frequent co-authors include Ana Peixoto, Catarina Santos, Carla Pinto, Rosalind A. Eeles, and Kenneth Muir, reflecting collaborative efforts across multiple projects.

Manuel R. Teixeira's research outputs have appeared in a variety of publication venues, including:

  • Cancers
  • Nature Communications
  • European Journal of Human Genetics
  • Scientific Reports
  • GE Portuguese Journal of Gastroenterology

Significant recent papers demonstrate a focus on cancer-related genomics and clinical implications. Notable examples include:

  • An integrative multi-omics analysis to identify candidate DNA methylation biomarkers related to prostate cancer risk (2020, Nature Communications)
  • Cancer Surveillance Guideline for individuals with PTEN hamartoma tumour syndrome (2020, European Journal of Human Genetics)
  • A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study (2021, The Lancet Oncology)
  • Hereditary Predisposition to Prostate Cancer: From Genetics to Clinical Implications (2020, International Journal of Molecular Sciences)
  • Genomic analysis of male puberty timing highlights shared genetic basis with hair colour and lifespan (2020, Nature Communications)

Their scientific contributions primarily address complex mechanisms underlying cancer susceptibility and progression, particularly in prostate cancer and hereditary cancer syndromes. This is supported by the strong emphasis on DNA repair mechanisms and cancer genomics found in their publications.

Best Publications

  • Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

    Fredrick R. Schumacher;Ali Amin Al Olama;Sonja I. Berndt;Sara Benlloch

  • Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array

    Rosalind A. Eeles;Ali Amin Al Olama;Sara Benlloch;Edward J. Saunders

  • The MLL recombinome of acute leukemias in 2013

    C. Meyer;J. Hofmann;T. Burmeister;D. Gröger

  • A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer

    Ali Amin Al Olama;Zsofia Kote-Jarai;Sonja I. Berndt;David V. Conti

  • Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.

    Timothy R. Rebbeck;Nandita Mitra;Fei Wan;Olga M. Sinilnikova

  • Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

    Catherine M Phelan;Karoline B Kuchenbaecker;Karoline B Kuchenbaecker;Jonathan P Tyrer;Siddhartha P Kar

  • Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.

    Roger L Milne;Roger L Milne;Karoline B Kuchenbaecker;Karoline B Kuchenbaecker;Kyriaki Michailidou;Kyriaki Michailidou;Jonathan Beesley

  • Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

    Haoyu Zhang;Haoyu Zhang;Thomas U. Ahearn;Julie Lecarpentier;Daniel Barnes

  • Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

    David V. Conti;Burcu F. Darst;Lilit C. Moss;Edward J. Saunders

  • SMARCB1/INI1 Tumor Suppressor Gene Is Frequently Inactivated in Epithelioid Sarcomas

    Piergiorgio Modena;Elena Lualdi;Federica Facchinetti;Lisa Galli

  • A quantitative promoter methylation profile of prostate cancer.

    Carmen Jerónimo;Rui Henrique;Rui Henrique;Mohammad O. Hoque;Elizabeth Mambo

  • Evaluation of polygenic risk scores for breast and ovarian cancer risk prediction in BRCA1 and BRCA2 mutation carriers

    Karoline B Kuchenbaecker;Karoline B Kuchenbaecker;Lesley McGuffog;Daniel Barrowdale;Andrew Lee

  • TMPRSS2-ERG Gene Fusion Causing ERG Overexpression Precedes Chromosome Copy Number Changes in Prostate Carcinomas and Paired HGPIN Lesions

    Nuno Cerveira;Franclim R. Ribeiro;Ana Peixoto;Vera Costa

  • Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemia

    Yilong Li;Claire Schwab;Sarra L. Ryan;Elli Papaemmanuil

  • Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

    Timothy R. Rebbeck;Tara M. Friebel;Eitan Friedman;Ute Hamann

  • Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study

    Elizabeth K. Bancroft;Elizabeth C. Page;Elena Castro;Hans Lilja

  • An integrative multi-omics analysis to identify candidate DNA methylation biomarkers related to prostate cancer risk.

    Lang Wu;Yaohua Yang;Xingyi Guo;Xiao Ou Shu

  • Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients

    J D Barros-Silva;D Leitão;L Afonso;J Vieira

  • Guidelines for the Li–Fraumeni and heritable TP53-related cancer syndromes

    Thierry Frebourg;Svetlana Bajalica Lagercrantz;Carla Oliveira;Rita Magenheim

  • Distinct high resolution genome profiles of early onset and late onset colorectal cancer integrated with gene expression data identify candidate susceptibility loci.

    Marianne Berg;Marianne Berg;Trude H. Ågesen;Trude H. Ågesen;Espen Thiis-Evensen;Marianne A. Merok

Frequent Co-Authors

Graham G. Giles
Graham G. Giles University of Melbourne
Kenneth W. Muir
Kenneth W. Muir University of Manchester
Johanna Schleutker
Johanna Schleutker Turku University Hospital
David E. Neal
David E. Neal University of Cambridge
Lisa A. Cannon-Albright
Lisa A. Cannon-Albright University of Utah
Rui Henrique
Rui Henrique University of Porto
Rosalind A. Eeles
Rosalind A. Eeles Institute of Cancer Research
Janet L. Stanford
Janet L. Stanford Fred Hutchinson Cancer Research Center
Melissa C. Southey
Melissa C. Southey Monash University
Jyotsna Batra
Jyotsna Batra Queensland University of Technology

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative online degrees can open diverse career pathways within healthcare beyond a traditional MD. Many students are now considering options such as health administration, nursing, pharmacy, and health information management to maximize career potential and work-life balance.

For those interested in leadership or healthcare management roles, several most affordable online mha programs offer flexible study options. Nurses seeking to become clinical experts or leaders might consider the cheapest dnp programs to upgrade their credentials.

If pharmacy interests you, many students are looking at pharmacy school online accredited—a convenient route to licensed practice. Additionally, with the growth in digital health records, accredited him programs prepare graduates for high-demand roles managing patient data.

Each program has unique admission requirements and outcomes, so research carefully to find the best match for your career goals in U.S. healthcare.

Best Scientists Citing Manuel R. Teixeira

Trending Scientists

Recently Published Articles